Draflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete Freunds adjuvant (CFA) model of mechanical hyperalgesia and the carrageenan inflammation model of thermal and mechanical hyperalgesia[1].
Molecular Weight:
604.52
Purity:
99.06
CAS Number:
[120770-34-5]
Formula:
C30H33Cl2F2N5O2
Target:
Adenosine Receptor,Nucleoside Transporters
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted